216 related articles for article (PubMed ID: 30560920)
1. Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia.
van Hooij A; Tjon Kon Fat EM; Batista da Silva M; Carvalho Bouth R; Cunha Messias AC; Gobbo AR; Lema T; Bobosha K; Li J; Weng X; Salgado CG; Spencer JS; Corstjens PLAM; Geluk A
Sci Rep; 2018 Dec; 8(1):17920. PubMed ID: 30560920
[TBL] [Abstract][Full Text] [Related]
2. Field-evaluation of a new lateral flow assay for detection of cellular and humoral immunity against Mycobacterium leprae.
Bobosha K; Tjon Kon Fat EM; van den Eeden SJ; Bekele Y; van der Ploeg-van Schip JJ; de Dood CJ; Dijkman K; Franken KL; Wilson L; Aseffa A; Spencer JS; Ottenhoff TH; Corstjens PL; Geluk A
PLoS Negl Trop Dis; 2014 May; 8(5):e2845. PubMed ID: 24810599
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
[TBL] [Abstract][Full Text] [Related]
4. Fingerstick test quantifying humoral and cellular biomarkers indicative for M. leprae infection.
Corstjens PLAM; van Hooij A; Tjon Kon Fat EM; Alam K; Vrolijk LB; Dlamini S; da Silva MB; Spencer JS; Salgado CG; Richardus JH; van Hees CLM; Geluk A
Clin Biochem; 2019 Apr; 66():76-82. PubMed ID: 30695682
[TBL] [Abstract][Full Text] [Related]
5. From genome-based in silico predictions to ex vivo verification of leprosy diagnosis.
Geluk A; Spencer JS; Bobosha K; Pessolani MC; Pereira GM; Banu S; Honoré N; Reece ST; MacDonald M; Sapkota BR; Ranjit C; Franken KL; Zewdie M; Aseffa A; Hussain R; Stefani MM; Cho SN; Oskam L; Brennan PJ; Dockrell HM;
Clin Vaccine Immunol; 2009 Mar; 16(3):352-9. PubMed ID: 19176694
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three immunological tests for leprosy diagnosis and detection of subclinical infection.
Lobato J; Costa MP; Reis Ede M; Gonçalves MA; Spencer JS; Brennan PJ; Goulart LR; Goulart IM
Lepr Rev; 2011 Dec; 82(4):389-401. PubMed ID: 22439279
[TBL] [Abstract][Full Text] [Related]
7. Spatial and temporal epidemiology of Mycobacterium leprae infection among leprosy patients and household contacts of an endemic region in Southeast Brazil.
Nicchio MV; Araujo S; Martins LC; Pinheiro AV; Pereira DC; Borges A; Antunes DE; Barreto JG; Goulart IM
Acta Trop; 2016 Nov; 163():38-45. PubMed ID: 27469619
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal.
Khadge S; Banu S; Bobosha K; van der Ploeg-van Schip JJ; Goulart IM; Thapa P; Kunwar CB; van Meijgaarden KE; van den Eeden SJ; Wilson L; Kabir S; Dey H; Goulart LR; Lobato J; Carvalho W; Bekele Y; Franken KL; Aseffa A; Spencer JS; Oskam L; Otttenhoff TH; Hagge DA; Geluk A
BMC Infect Dis; 2015 Oct; 15():477. PubMed ID: 26510990
[TBL] [Abstract][Full Text] [Related]
9. Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.
Hungria EM; Oliveira RM; Souza AL; Costa MB; Souza VN; Silva EA; Moreno FR; Nogueira ME; Costa MR; Silva SM; Bührer-Sékula S; Reed SG; Duthie MS; Stefani MM
Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():104-11. PubMed ID: 23283461
[TBL] [Abstract][Full Text] [Related]
10. Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil.
Leturiondo AL; Noronha AB; do Nascimento MOO; Ferreira CO; Rodrigues FDC; Moraes MO; Talhari C
BMC Infect Dis; 2019 Jan; 19(1):22. PubMed ID: 30616580
[TBL] [Abstract][Full Text] [Related]
11. Latent leprosy infection identified by dual RLEP and anti-PGL-I positivity: Implications for new control strategies.
da Silva MB; Li W; Bouth RC; Gobbo AR; Messias ACC; Moraes TMP; Jorge EVO; Barreto JG; Filho FB; Conde GAB; Frade MAC; Salgado CG; Spencer JS
PLoS One; 2021; 16(5):e0251631. PubMed ID: 33984058
[TBL] [Abstract][Full Text] [Related]
12. Leprosy surveillance study in a highly endemic Brazilian area using leprosy specific serologic tests and IFNγ whole blood assay.
do Carmo Gonçalves A; Hungria EM; Freitas AA; Sékula-Bührer S; Gomes CM; Coelho AC; Nascimento LB; de Araújo Stefani MM
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2345-2360. PubMed ID: 32666479
[TBL] [Abstract][Full Text] [Related]
13. Household Contacts of Leprosy Patients in Endemic Areas Display a Specific Innate Immunity Profile.
van Hooij A; Tió-Coma M; Verhard EM; Khatun M; Alam K; Tjon Kon Fat E; de Jong D; Sufian Chowdhury A; Corstjens P; Richardus JH; Geluk A
Front Immunol; 2020; 11():1811. PubMed ID: 32849645
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
[TBL] [Abstract][Full Text] [Related]
15. Application of new host biomarker profiles in quantitative point-of-care tests facilitates leprosy diagnosis in the field.
van Hooij A; van den Eeden S; Richardus R; Tjon Kon Fat E; Wilson L; Franken KLMC; Faber R; Khatun M; Alam K; Sufian Chowdhury A; Richardus JH; Corstjens P; Geluk A
EBioMedicine; 2019 Sep; 47():301-308. PubMed ID: 31422044
[TBL] [Abstract][Full Text] [Related]
16. Host immune responses induced by specific Mycobacterium leprae antigens in an overnight whole-blood assay correlate with the diagnosis of paucibacillary leprosy patients in China.
Chen X; You YG; Yuan YH; Yuan LC; Wen Y
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007318. PubMed ID: 31017900
[TBL] [Abstract][Full Text] [Related]
17. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
[TBL] [Abstract][Full Text] [Related]
18. New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.
Geluk A; Bobosha K; van der Ploeg-van Schip JJ; Spencer JS; Banu S; Martins MV; Cho SN; Franken KL; Kim HJ; Bekele Y; Uddin MK; Hadi SA; Aseffa A; Pessolani MC; Pereira GM; Dockrell HM; Ottenhoff TH
J Immunol; 2012 May; 188(10):4782-91. PubMed ID: 22504648
[TBL] [Abstract][Full Text] [Related]
19. Antigen-specific secretion of IFNγ and CXCL10 in whole blood assay detects Mycobacterium leprae infection but does not discriminate asymptomatic infection from symptomatic leprosy.
Hungria EM; Freitas AA; Pontes MA; Gonçalves HS; Sousa AL; Costa MB; Castilho ML; Duthie MS; Stefani MM
Diagn Microbiol Infect Dis; 2017 Apr; 87(4):328-334. PubMed ID: 28126361
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.
Parkash O; Kumar A; Nigam A; Franken KL; Ottenhoff TH
Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
